Zhejiang Shouxiangu Pharm Co (603896) - Total Liabilities
Based on the latest financial reports, Zhejiang Shouxiangu Pharm Co (603896) has total liabilities worth CN¥841.89 Million CNY (≈ $123.19 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore cash efficiency ratio of Zhejiang Shouxiangu Pharm Co to assess how effectively this company generates cash.
Zhejiang Shouxiangu Pharm Co - Total Liabilities Trend (2012–2024)
This chart illustrates how Zhejiang Shouxiangu Pharm Co's total liabilities have evolved over time, based on quarterly financial data. Check 603896 asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Zhejiang Shouxiangu Pharm Co Competitors by Total Liabilities
The table below lists competitors of Zhejiang Shouxiangu Pharm Co ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
TPI Polene Power Public Company Limited
BK:TPIPP
|
Thailand | ฿32.41 Billion |
|
BlackRock Health Sciences Trust
NYSE:BME
|
USA | $1.83 Million |
|
Kumho HT Inc
KO:214330
|
Korea | ₩119.57 Billion |
|
Shanghai Yongguan Adhesive Products Corp Ltd
SHG:603681
|
China | CN¥4.35 Billion |
|
Ningbo Bird Co Ltd
SHG:600130
|
China | CN¥158.64 Million |
|
Suqian Unitech Corp. Ltd. Cl A
SHG:603065
|
China | CN¥1.47 Billion |
|
Bansal Wire Industries Ltd
NSE:BANSALWIRE
|
India | Rs9.33 Billion |
|
Earth-Panda Advanced Magnetic Material Co Ltd
SHG:688077
|
China | CN¥1.63 Billion |
Liability Composition Analysis (2012–2024)
This chart breaks down Zhejiang Shouxiangu Pharm Co's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Zhejiang Shouxiangu Pharm Co market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.82 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.36 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.27 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Zhejiang Shouxiangu Pharm Co's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Zhejiang Shouxiangu Pharm Co (2012–2024)
The table below shows the annual total liabilities of Zhejiang Shouxiangu Pharm Co from 2012 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CN¥837.17 Million ≈ $122.50 Million |
-16.54% |
| 2023-12-31 | CN¥1.00 Billion ≈ $146.78 Million |
+5.51% |
| 2022-12-31 | CN¥950.67 Million ≈ $139.11 Million |
+177.64% |
| 2021-12-31 | CN¥342.41 Million ≈ $50.11 Million |
-8.27% |
| 2020-12-31 | CN¥373.28 Million ≈ $54.62 Million |
+121.77% |
| 2019-12-31 | CN¥168.31 Million ≈ $24.63 Million |
-18.61% |
| 2018-12-31 | CN¥206.79 Million ≈ $30.26 Million |
+265.38% |
| 2017-12-31 | CN¥56.60 Million ≈ $8.28 Million |
-67.69% |
| 2016-12-31 | CN¥175.17 Million ≈ $25.63 Million |
-26.21% |
| 2015-12-31 | CN¥237.38 Million ≈ $34.74 Million |
+31.56% |
| 2014-12-31 | CN¥180.43 Million ≈ $26.40 Million |
+64.24% |
| 2013-12-31 | CN¥109.85 Million ≈ $16.07 Million |
-19.01% |
| 2012-12-31 | CN¥135.64 Million ≈ $19.85 Million |
-- |
About Zhejiang Shouxiangu Pharm Co
Zhejiang Shouxiangu Pharmaceutical Co., Ltd. engages in the selection, cultivation, processing, and sale of medicinal materials in China. It offers Ganoderma lucidum spore powder and brand broken cell wall powder, as well as broken wall Ganoderma lucidum spore powder granules and powder tablets; Tiepi Fengdou granules; and Tiepi Fengdou Ganoderma lucidum extracts. The company offers its products … Read more